Tag Archives: Medical Marijuana Inc

SeeThruEquity RSHO

Medical Marijuana, Inc. Announces State of Mexico’s Historic Purchase of Company’s Cannabis Product for Its Citizens

Medical Marijuana, Inc. Announces State of Mexico’s Historic Purchase of Company’s Cannabis Product for Its Citizens

SAN DIEGO, Aug. 21, 2017 /Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that the State of Mexico’s government has purchased the company’s Real Scientific Hemp Oil-X™ (RSHO-X™) CBD hemp oil products from its subsidiary HempMeds Mexico® to treat 11 of its citizens suffering from varying indications including Refractory Epilepsy and Lennox Gastaut-Syndrome.

SeeThruEquity RSHO

SeeThruEquity Initiates Coverage On Medical Marijuana, Inc. Investment Company AXIM Biotech (OTC: AXIM) With A Target Price Of $17.00

SAN DIEGO, Calif., May 17, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM) received coverage initiation from SeeThruEquity, a leading independent equity research firm focused on smallcap and microcap public companies, with a price target of $17.00.

Could Canadian Legalization of Recreational MJ Help US Pot Stocks?

Could Canadian Legalization of Recreational MJ Help US Pot Stocks?

Prime Minister Justin Trudeau recently introduced legislation to legalize use of recreational marijuana in Canada. While legalization should help Canadian marijuana providers, could it also provide a boost to U.S. marijuana stocks?

Americans for Safe Access Opioid Veterans Senate Committee

Cannabis Patients, Advocates, and Industry Leaders Converge at National Medical Cannabis Unity Conference in D.C.

WASHINGTON, March 28, 2017 /Weed Wire/ — Starting on Friday, April 7th and running until Tuesday, April 11th, medical cannabis industry business leaders, medical and legal professionals, advocates, and patients will gather at the Unity 2017 conference in Washington, D.C. to discuss common-sense policies and approaches to safe medical cannabis access and use. With the uncertainty of policies under a new U.S. administration, 2017 will be one of the most important years for medical cannabis policy ever.

SeeThruEquity RSHO

Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Term Sheet Agreement With U.S. API Company To Develop Bioequivalent Product To Marinol

SAN DIEGO, Calif., March 28, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB: AXIM), has entered into a Term Sheet Agreement with a U.S.-based controlled-substances API (Active Pharmaceutical Ingredient) production company to develop a dronabinol-based functional, controlled-release chewing gum product based on AXIM IP and technology.

SeeThruEquity RSHO

Medical Marijuana, Inc. Investment AXIM Biotech Retains Ora To Manage Upcoming Product Development And Clinical Trials On Glaucoma And Dry Eye Indications

NEW YORK, March 21, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, has retained the services of Ora®, Inc.,

SeeThruEquity RSHO

Study Results: Medical Marijuana, Inc. Subsidiary HempMeds Mexico Announces Release of Study Using Its Real Scientific Hemp Oil-X to Treat Epileptic Children

SAN DIEGO, Calif., March 14, 2017 /Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Mexico is holding a press conference in Mexico City, Mexico, today to reveal the positive results of a recent study conducted by renowned Mexican physician Dr. Saul Garza Morales on the effects of the Company’s Real Scientific Hemp Oil-X™ (RSHO-X™) product in treating children with severe epilepsy.

SeeThruEquity RSHO

Medical Marijuana, Inc. Investment Axim Biotech Announces Enrolled Patients Begin Phase II Trial for the Treatment of Irritable Bowel Syndrome (IBS) with CanChew Plus Cannabidiol (CBD) Chewing Gum

NEW YORK, March 7, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has enrolled 40 patients and commenced its Phase II clinical trial for the treatment of irritable bowel syndrome (IBS) with the company’s CanChew Plus® CBD gum.

SeeThruEquity RSHO

Medical Marijuana, Inc. Clarifies Operations Unaffected by White House Statements Hinting at Recreational Marijuana Crackdown

SAN DIEGO, Calif., March 1, 2017/Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, is reassuring customers, shareholders, and the public that the company’s operations in the federally legal hemp cannabidiol (CBD) market are unaffected by recent statements from Trump administration officials hinting at a crackdown on recreational marijuana.

SeeThruEquity RSHO

Medical Marijuana, Inc. Receives Brazilian Government Approval for Treatment of Autism Patient Using, Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

SAN DIEGO, Calif., March 3, 2017/Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States subsidiary, HempMeds® Brasil, today announced that the Brazilian government approved a prescription for the Company’s cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat a patient in the country with Autism Spectrum Disorder (ASD).

Medical Marijuana Inc Fails To Delight Investors

Medical Marijuana Inc Fails to Delight Investors

In the last trading session, the stock price of Medical Marijuana Inc (OTCMKTS:MJNA) declined more than 8% to close the day at $0.112. The decline came at a share volume of 24.74 million compared to average share volume of 17.32 million.

SeeThruEquity RSHO

Multiple Sclerosis Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™

SAN DIEGO, Calif., Feb. 21, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat patients in the country suffering from Multiple Sclerosis.

Top 3 Most Attractive Investment Subsets Of The Cannabis Industry

Top 3 Most Attractive Investment Subsets of the Cannabis Industry

The cannabis industry is expected to reach $50 billion in size by 2026, according to Cowen & Co., making it one of the fastest growing industries in the world. Investors have taken a growing interest in the industry as legalization has spread across North America. Here are three subsets of the cannabis industry that investors may want to consider for the best risk-adjusted returns.

SeeThruEquity RSHO

Medical Marijuana Inc. Subsidiary, HempMeds, Announces New Affiliate Program Showcasing Customer Loyalty

SAN DIEGO, Calif., Feb. 13, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds® is announcing a new affiliate program showcasing customer loyalty by allowing them to earn a commission by referring customers to the company.

Brazilian Supreme Court Justice Calls For Legalization of Marijuana

Brazilian Supreme Court Justice Calls For Legalization of Marijuana

A justice on the Brazilian Supreme Court has called for the legalization of marijuana and even harder drugs as a means to ending violence among drug gangs, according to a Feb. 10, 2017, article from Reuters. The justice, Roberto Barroso, is a constitutional law professor who was educated at Yale University in the United States.

SeeThruEquity RSHO

Alzheimer’s Patient Receives Brazilian Government Permission to be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

SAN DIEGO, Calif., Feb., 7, 2017/Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat a patient in the country suffering from Alzheimer’s disease.

SeeThruEquity RSHO

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Recognizes One-Year Anniversary of First RSHO-X™ Import Permit

SAN DIEGO, Jan. 31, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA), the first publicly traded cannabis company in the United States, is proud to announce the progress made by subsidiary HempMeds® Mexico upon the one-year anniversary of the first-ever import permit for RSHO-X™ into Mexico.

SeeThruEquity RSHO

Medical Marijuana Inc. Subsidiary Kannaway® Announces Launch of a New Product— “Kannaway® Gold Premium Hemp Oil”

SAN DIEGO, Jan. 25, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), announced today that its subsidiary Kannaway® LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has unveiled a new premium hemp oil product – Kannaway Gold.

SeeThruEquity RSHO

Medical Marijuana, Inc. Subsidiary HempMeds Mexico® Receives COFEPRIS Permission for Flagship Product RSHO-X™ Usage for Cancer Patient

SAN DIEGO, Jan. 24, 2017/Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds Mexico® has received permission from Mexico’s health authority COFEPRIS to import their flagship product Real Scientific Hemp Oil-X™ (RSHO-X™) to treat a patient for their pain associated with cancer treatments and for their general well-being.

SeeThruEquity RSHO

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red Carpet Event in Atlanta, Georgia

SAN DIEGO, Jan. 13, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary, Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is holding an exclusive Red Carpet Event in Atlanta, Ga., this weekend.

SeeThruEquity RSHO

Forbes Features Medical Marijuana, Inc. in Article Citing Company’s Sales Data After Starting CBD Market ‘That Could Grow 700% by 2020’

SAN DIEGO, Dec. 14, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company, its products and investments were featured in a Forbes article focused on the current cannabidiol (CBD) market size and anticipated massive growth.

SeeThruEquity RSHO

Medical Marijuana, Inc.’s Investment Axim(R) Biotech Files IP Application on Proprietary Method to Extract High-Purity THC

SAN DIEGO, Nov. 29, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC PINK: AXIM) has filed an IP application with the World Intellectual Property Organization.

SeeThruEquity RSHO

Medical Marijuana, Inc. Subsidiary HempMeds(R) Mexico Begins Distribution of Flagship Product Real Scientific Hemp Oil(TM) to Colombian Market

SAN DIEGO, Calif., Nov. 28, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its subsidiary HempMeds® Mexico, the first and only company with approval from COFEPRIS to legally import a cannabis product into Mexico, has begun distributing Real Scientific Hemp Oil™ (RSHO™) to Colombia.

SeeThruEquity RSHO

Medical Marijuana, Inc.’s Kannaway, LLC Launches Refresh of World-Renowned Brand at ‘Genesis’ Event in San Diego

SAN DIEGO, Calif., Nov. 21, 2016 /Weed Wire/ — Medical Marijuana, Inc. announced today that its portfolio company Kannaway launched a refresh of its world-renowned brand at its `Genesis: People, Purpose, Passion’ event in San Diego this November.

SeeThruEquity RSHO

Medical Marijuana, Inc.’s Kannaway, LLC to Add New Rev!ve(TM) Pro-X to Line of CBD Hemp Oil Lifestyle Products

SAN DIEGO, Aug. 29, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its portfolio company Kannaway, LLC, the first hemp lifestyle network marketing company to offer cannabidiol (CBD) hemp botanical products, is adding a zero-THC version of its popular Rev!ve™ formula.

SeeThruEquity RSHO

Medical Marijuana, Inc. and Subsidiary HempMeds Partner With CannaNative(TM) to Produce First-Ever Cannabis Product Line for Native American Marketplace

SAN DIEGO, Calif., Aug. 15, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) and its subsidiary HempMeds® announced today a partnership with CannaNative™, LLC (“CannaNative™”) to produce the first-ever cannabis product line for the Native American marketplace.

SeeThruEquity RSHO

Medical Marijuana, Inc.’s Subsidiary HempMeds(R) Mexico to Sponsor and Exhibit at Expoweed Conference in Mexico City

SAN DIEGO, Calif., Aug. 12, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its subsidiary HempMeds® Mexico is sponsoring and exhibiting at the Aug. 12-14 ExpoWeed Conference, the first-ever cannabis conference to be held in Mexico.

SeeThruEquity RSHO

Medical Cannabis Activist Raul Elizalde to Join Medical Marijuana, Inc. at Southern California Cannabis Conference and Expo

SAN DIEGO, Aug. 3, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that medical cannabis activist Raul Elizalde of Mexico will join Company representatives at the Southern California Cannabis Conference and Expo (SocalCCExpo) at the San Diego Convention Center to discuss his fight to unify the voices of families and patients in need of medical cannabis in Mexico.

SeeThruEquity RSHO

Medical Marijuana, Inc. Hires New Director of Human Resources to Support Company’s Rapid Growth, International Expansion

SAN DIEGO, Aug. 1, 2016/Weed Wire/ — Medical Marijuana, Inc.’s (OTC PINK: MJNA) management team today announced that Melissa Temple-Agosta has been hired as Director of Human Resources, reporting directly to Senior Vice President of Operations Blake Schroeder.

SeeThruEquity RSHO

Medical Marijuana, Inc. Now Hiring for Sales and Marketing Positions for Booming Cannabis Industry

SAN DIEGO, July 28, 2016 /Weed Wire/ — Medical Marijuana, Inc.’s (OTC PINK: MJNA) management team announced today that it’s currently hiring for open sales and marketing positions, as the Company continues its rapid expansion.

SeeThruEquity RSHO

Medical Marijuana, Inc. Portfolio Company Kannalife Featured in Sports Illustrated Article About Research That Could Be “Future New Wave of Medicine”

SAN DIEGO, Calif., July 15, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its portfolio company Kannalife Sciences, Inc. was the focus of a Sports Illustrated online article about how the breakthrough cannabinoid research the Company is conducting could be the “future new wave of medicine” for traumatic brain injuries.

CFN MediaGroup

CFN Media Examines Medical Marijuana, Inc.’s Investment in AXIM Biotechnolgies’ Groundbreaking CBD and CBG Research

REDONDO, Calif., July 14, 2016 /Weed Wire/ — CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article and interview discussing Medical Marijuana Inc.’s (OTC PINK: MJNA) major investment in AXIM Biotechnologies.

SeeThruEquity RSHO

Medical Marijuana, Inc. Receives New Permit to Export Into Paraguay, Plans New Latin America Expansion

SAN DIEGO, Calif., July 5, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that the Paraguay government has issued a new import permit for the Company’s flagship product Real Scientific Hemp Oil™ (RSHO™) for a new patient in the country.

MJNA and AXIM

Medical Marijuana, Inc. (MJNA) Appoints Blake N. Schroeder, Esq., As Vice President of Operations

SAN DIEGO, March 29, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) is proud to announce to shareholders and the public that the global industrial hemp investor and innovator has appointed Blake N. Schroeder, Esq., as Vice President of Operations at Medical Marijuana, Inc.

Industrial Technology Innovations for the Legal Marijuana Industry Lead to Advanced Cultivation Operations as Revenue Potential Continues to Grow

CORAL SPRINGS, Florida, May 20, 2015 /PRNewswire/ — As more U.S. states loosen their policies on recreational and medical marijuana operations, companies are racing to become the industry leaders in cultivation technology for growing cannabis and hemp industry innovators.

medicalmarijuanadoctor

Medical Marijuana Inc.’s HempMeds Showcases CBD-Rich Hemp Oil Products at A4M World Congress

SAN DIEGO, May 16, 2014 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce that its portfolio company, HempMeds(TM), is exhibiting at the American Academy of Anti-Aging Medicine (A4M) Orlando World Congress May 16-17. A continuing medical education (CME) course on cannabidiol (CBD) will be offered by a licensed Medical Doctor to


Top